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Chemical chaperone TUDCA 
prevents apoptosis and improves 
survival during polymicrobial sepsis 
in mice
Marcel Doerflinger1, Jason Glab1, Christina Nedeva1, Irvin Jose1, Ann Lin2, Lorraine O’Reilly2,3, 
Cody Allison2,3, Marc Pellegrini2,3, Richard S. Hotchkiss4 & Hamsa Puthalakath1
Sepsis-induced lymphopenia is a major cause of morbidities in intensive care units and in populations 
with chronic conditions such as renal failure, diabetes, HIV and alcohol abuse. Currently, other than 
supportive care and antibiotics, there are no treatments for this condition. We developed an in vitro 
assay to understand the role of the ER-stress-mediated apoptosis process in lymphocyte death during 
polymicrobial sepsis, which was reproducible in in vivo mouse models. Modulating ER stress using 
chemical chaperones significantly reduced the induction of the pro-apoptotic protein Bim both in vitro 
and in mice. Furthermore, in a ‘two-hit’ pneumonia model in mice, we have been able to demonstrate 
that administration of the chemical chaperone TUDCA helped to maintain lymphocyte homeostasis by 
significantly reducing lymphocyte apoptosis and this correlated with four-fold improvement in survival. 
Our results demonstrate a novel therapeutic opportunity for treating sepsis-induced lymphopenia in 
humans.
In the United States alone, ∼ 750000 individuals develop sepsis (or colloquially known as blood poisoning), and of 
these ∼ 30% succumb to this disorder annually. Sepsis is the 10th leading cause of death, with an enormous finan-
cial burden (sepsis costs between US$25,000 and US$50,000 per episode1). Though better treatment methods 
have improved overall patient survival, sepsis is still a major health and economic strain due to an ageing popu-
lation2. Sepsis is defined as the host inflammatory response to severe, life-threatening infection with the presence 
of organ dysfunction. The host immune response to sepsis can be divided into two stages, a hyper-inflammatory 
phase and a hypo-inflammatory phase. During the hyper-inflammatory phase, activated immune cells (mostly 
the innate immune system) produce copious amounts of inflammatory cytokines, which can result in multiple 
organ failure. However, improved treatment protocols have resulted in most patients surviving this stage and 
entering a protracted immune suppressive phase3. The latter phase is characterized by extensive apoptosis in the 
cells of the adaptive immune system, i.e., B cells, and T cells2 leading to prolonged lymphopenia. The severe lym-
phopenia and other accompanying immune defects render patients unable to clear their primary infection and 
susceptible to lethal nosocomial infections.
Experimental drug therapies for sepsis are currently at a crossroad with more than 30 drug trials failing 
in the last 25 years. These include, but not limited to, Eritoran or anti-TLR4 compound (Eisai Co. Ltd, Japan), 
Xigris or activated protein C (Eli Lilly & Co. USA), CytoFab or anti-TNFα antibody (AstraZeneca, Sweden) and 
Talactoferrin alfa, an immuno-modulatory lactoferrin (Agennix, Germany) to name a few. Failure of these trials 
of different anti-inflammatory agents highlights the fact that inflammation is not the key driving mechanism of 
sepsis-related fatalities. There is an inverse correlation between immune cell apoptosis and patient survival i.e. 
lymphocyte apoptosis is the major reason for most fatalities associated with sepsis3,4. The pro-apoptotic pro-
tein Bim is considered to be an essential initiator of apoptosis in a wide variety of physiological settings and 
especially in lymphocyte homeostasis5. While the role of Bim-mediated lymphocyte apoptosis in sepsis is well 
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documented6,7 and Bim is induced to very high levels in lymphocytes from patients with early stage severe sepsis8, 
the exact mechanism of this cell death is unknown. We have previously shown that ER-stress mediated apoptosis 
is regulated by Bim in numerous cell types including lymphocytes9.
In the present study, we demonstrate that ER-stress during sepsis induces Bim-mediated lymphocyte death. 
Modulating endoplasmic stress (ER stress) by chemical chaperones significantly reduces Bim up-regulation and 
improves survival in a mouse two-hit sepsis model. Our study defines a novel therapeutic strategy for treating 
sepsis with Gram-negative bacterial infections.
Results
Development of an in vitro system to study role of ER stress in lymphopenia. Apoptosis of lym-
phocytes and antigen presenting cells is considered to be a hallmark of the immune suppressive phase of sepsis 
and correlates with patient death2,4. Macrophages play a key role in sepsis-mediated apoptosis, as they are both the 
sentinels and the first line of defense against infection and can modulate the host immune response as producers 
of a wide range of pro/anti-inflammatory cytokines and chemokines10. Pertinently, it has been reported that the 
serum derived from sepsis patients contains a circulating factor capable of inducing apoptosis in hematopoietic 
cells in vitro11. To understand the kinetics of gene regulation both at protein and mRNA levels and to study the 
effect of chemical chaperones, we developed an in vitro sepsis assay. In this assay, we activated the murine mac-
rophage cell line RAW264.7 or in vitro differentiated human macrophages or macrophage cell lines with bacte-
rial lipopolysaccharide (LPS; 100 ng/ml). The conditioned medium 24-hours post activation was harvested and 
the target cells (mouse primary thymocytes and splenic B cells, HAO dendritic cells, embryonic fibroblasts and 
human Jurkat T cells) were treated with this supernatant to assess their Bim induction and apoptotic response. 
As shown in Fig. 1A,C, splenic B cells, thymocytes and mouse embryonic fibroblasts (MEFs) showed a Bim-
dependent apoptosis. This apoptosis response is accompanied by induction of Bim at both protein and tran-
script levels (Fig. 1B–D). In addition to murine macrophages, we tested the ability of the human macrophage cell 
lines (THP1 and U937) and human peripheral blood monocytes-derived macrophages to induce Bim in target 
cells (MEFs). In all cell lines tested, a reproducible Bim induction was observed (Fig. 2A,B). Bim induction in 
MEFs and Jurkat cells as well as primary thymocytes was accompanied by the up-regulation of ER stress markers 
including the ER chaperone BiP (Figs 1C,D and 2B) and spliced XBP1 (Fig. 3A). This upregulation appeared to 
be modulated by structurally dissimilar chemical chaperones with UPR modulating ability such as Genistein12, 
compound c/dorsomorphin13 and Tauroursodeoxycholic acid (TUDCA)14 (Fig. 3B). This suggested that up-reg-
ulation of Bim during sepsis could be mediated by the ER-stress response.
Development of an in vivo system for sepsis and lymphopenia. One of the most widely used sepsis 
models is intravenous/intraperitoneal injection of lipopolysaccharide (LPS) in mice15. This is based on the fact 
that in the majority of sepsis cases, Gram-negative bacteria are involved in the pathogenesis. However, in contrast 
to the responses observed following bacterial infections, LPS infusion models often do not mimic the changes 
observed during sepsis16. Moreover, the cytokine induction seen after LPS injection is a pre-requirement for the 
activation of the adaptive immune system17, though in a minority of cases, the resulting cytokine storm could lead 
to fatal organ failure18. This led to the development of a more appropriate model i.e. Cecal Ligation and Puncture 
(CLP), which mimics the clinical course of intra-abdominal sepsis19. CLP is considered to be the gold-standard 
model for sepsis, however, it is a highly invasive procedure that requires extensive training and severity and symp-
toms can vary significantly depending on the position of the ligation20. For our experiments, we followed a far sim-
pler procedure with highly reproducible results where mice were injected (i.p) with cecal slurry (CS) prepared in 
5% dextrose21. In this model, varying the amount of cecal slurry injected into the mice i.e. between 0.5 g–2.0 g/kg 
bodyweight, allows us to modulate the severity of disease in a reproducible fashion. Next, we wanted to test if 
both the apoptotic response and Bim induction in this setting were similar to that which has been reported for the 
CLP-based sepsis model6. As shown in Fig. 4A,B, the apoptotic response of thymocytes and splenocytes was sim-
ilar previously published reports6. Injection of cecal slurry elicited a Bim-dependent apoptotic response i.e. there 
was a significant reduction in apoptosis in BIM−/− mice compared with WT mice. These findings were further 
confirmed by Western blot analysis of Bim protein in the spleen and thymus, in addition to absolute quantifica-
tion of BIM transcripts by digital PCR analysis (Fig. 4B). Taken together, these results suggest that the cecal slurry 
injection model agrees well with the CLP model both in terms of apoptotic response and Bim induction kinetics.
ER stress induces Bim during sepsis. Although multiple BH3-only proteins can be induced during ER 
stress-induced apoptosis9, Bim is the major regulator of lymphocyte homeostasis22. Additionally in CLP models, 
ER-stress is known to contribute to abnormal lymphocyte apoptosis23. We therefore wanted to test if lymphocytes 
from mice undergoing sepsis in the cecal slurry injection model were under ER stress and whether modulation of 
ER stress would reduce Bim induction levels and apoptosis as we observed in our in vitro model.
We found that, cecal slurry injection did indeed result in a significant induction of the ER chaperone BiP, 
(Figs 4B and 5A,B) accompanied by increased expression of the transcription factor Chop, two known markers of 
ER stress24, in thymocytes and splenocytes (Fig. 5B). This was associated with both induction in Bim and apopto-
sis. However, treating these mice with the chemical chaperone TUDCA resulted in a significant reduction in the 
levels of the ER stress markers and Bim, suggesting that ER stress could be contributing to the up-regulation of 
Bim during sepsis. Furthermore, TUDCA treatment resulted in a significant reduction in lymphocyte apoptosis, 
assessed by both flow cytometry and TUNEL staining of splenic sections (Fig. 5A,B). Taken together, these results 
suggest that alleviating ER-stress induction with chemical chaperones could be a potential therapeutic strategy 
for treating sepsis.
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Figure 1. Macrophage conditioned medium induces apoptosis and Bim induction in vitro. RAW264.7 cells 
were activated with LPS (100 ng/ml) for 24 hours and the medium was used for treating target cells. In each case, 
apoptosis was measured by annexin V-PI staining. For protein analysis by Western blots and mRNA analysis 
by droplet digital PCR. (A) Mouse thymocytes and splenic B cells from WT or BIM−/− mice were treated with 
the conditioned medium and apoptosis was measured after 24 hours. Thymocytes treated with the conditioned 
medium were analysed by Western blot for BiP and Bim induction after 6 hours (right). (B) HAO cells were 
treated as in (A) and BIM and PUMA mRNA (left) and protein induction (right) were measured at the indicated 
time points. (C) MEFs from WT, BIM−/− and BAX−/−/BAK−/− mice were treated as in (A) and apoptosis (left) 
and Bim protein induction (right) were analysed. (D) Jurkat T cells were treated for indicated time points (h) 
and apoptosis and Bim protein induction were analysed. Error bars + /− SEM; n = 3; unpaired, two-tailed 
Student’s t - test. *p < 0.05.
www.nature.com/scientificreports/
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Chemical chaperone administration improves survival in mice in a two-hit pneumonia model. 
In the majority of currently utilized animal models of sepsis, mortality occurs within the first 3 days i.e. before 
the animals elicit the adaptive immune response. In contrast, most patients die of sepsis after 3 days of infec-
tion due to immune paralysis leading to ventilator-associated pneumonia. To address this apparent disparity, the 
Hotchkiss group have developed a clinically relevant “two-hit” model of sepsis where mice are challenged with 
Pseudomonas aeruginosa, an opportunistic pathogen, after the onset of immune suppression25. We adapted this 
“two-hit” model to test the efficacy of ER-stress alleviation with the chemical chaperone TUDCA. Our results 
show that when mice were injected with either PBS or with cecal slurry followed by TUDCA, allowed to recover 
Figure 2. Conditioned media from activated human macrophage cell lines and primary cells induce 
Bim-mediated apoptosis in target cells. (A) THP-1 and U937 cells (human macrophage cell lines) were 
activated with LPS (100 ng/mL) and deoxynivalenol (DON) (200 ng/mL) and the conditioned medium was 
collected. The target cells (MEFs) were treated with this conditioned medium and apoptosis was measured 
after 48 h by annexin V-PI staining (left) or Bim induction was analysed by Western blot. Conditioned medium 
from activated RAW264.7 cells was used as positive control. (B) Human peripheral blood monocytes were 
differentiated into macrophages and were treated with LPS and DON. The conditioned medium was used 
to treat the target cells (MEFs). ER stress protein BiP and Bim induction was analysed by Western blot and 
apoptosis was measured by annexin V-PI staining after 48 h. Error bars + /− SEM; n = 3; unpaired, two-tailed 
Student’s t - test. *p < 0.005.
www.nature.com/scientificreports/
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Figure 3. Conditioned medium from activated macrophage cell lines induces ER stress target cells and this 
can be alleviated by chemical chaperones. (A) MEFs were treated with the conditioned medium and XBP1 
splicing was analysed at the indicated time points by digital droplet PCR (left) or by conventional PCR (right). 
Tunicamycin (200 ng/ml) was used as positive control. (B) MEFs were treated with the conditioned medium in 
the absence or in the presence of chemical chaperones TUDCA (1 mg/mL), compound C (1 μ M), Genistein 
(5 μM) and the apoptosis response after 24 h was measured by annexin V-PI staining (left) and Bim/BiP protein 
modulation was assessed by Western blot (right). XBP1 splicing in MEFs treated with conditioned medium and 
TUDCA was assessed by PCR (bottom). The spliced and unspliced forms of Xbp-1 are indicated. Error bars  
+ /− SEM; n = 3; unpaired, two-tailed Student’s t - test. *p < 0.05.
www.nature.com/scientificreports/
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and then challenged intra-nasally with P. aeruginosa, the mice injected with cecal slurry were more susceptible 
to P. aeruginosa compared to sham injected mice (Fig. 5C). Administration of TUDCA post cecal slurry injec-
tion significantly improved the survival rate i.e. a 4-fold survival advantage compared to cecal slurry only. This 
survival advantage could not be attributed to differences in pro-inflammatory cytokine secretion, since TUDCA 
injection did not lead to any significant difference in the serum cytokine levels between cecal slurry alone or cecal 
slurry plus TUDCA injected mice, whereas significant reduction in thymic and splenic Bim levels in these mice 
was indeed noted (Fig. 6A,B).
Discussion
Our present results corroborate our earlier finding that Bim is a mediator of cellular homeostasis during ER 
stress-mediated apoptosis9. Furthermore, we have provided convincing evidence that ER stress is the main insti-
gator of Bim induction and is associated with lymphocyte apoptosis during sepsis. TUDCA is a hydrophilic 
Figure 4. Polymicrobial sepsis in mice elicits Bim-dependent apoptosis. Polymicrobial sepsis was induced by 
cecal slurry injection in WT and BIM−/− mice. (A) 24 hours post-injection, total cellularity and apoptosis were 
measured by FACS analysis. (B) At the indicated time points after the cecal slurry injection, thymic and splenic 
tissue was harvested and analysed for Bim protein induction by Western blot (left) or BIM mRNA induction 
by digital PCR analysis (right). Error bars + /− SEM; n = 3; unpaired, two-tailed Student’s t - test. *p < 0.05 and 
#statistically non-significant.
www.nature.com/scientificreports/
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Figure 5. TUDCA treatment significantly reduces ER stress, and improves survival during polymicrobial 
sepsis. (A) Mice were injected with cecal slurry with or without TUDCA and thymic samples were analysed 
at the indicated time point for ER stress marker protein BiP and Bim (left) and 24 hour later for apoptosis by 
annexin V-PI staining (right). (B) Splenic samples from septic mice were harvested after 8 h and analysed for 
ER stress markers (left), apoptosis induction was assessed by TUNEL staining after 24 h (right). The arrowheads 
indicate TUNEL positive cells. The graph in the middle is quantitation of TUNEL positive cells. (C) Mice were 
sham injected or with cecal slurry + /− TUDCA and allowed to recover. On day 3, intra-nasal inoculation 
of P. aeruginosa was performed and survival was measured. Error bars + /− SEM (A) or + /− SD (B); n = 3; 
unpaired, two-tailed Student’s t - test. *p < 0.005. (C) Log-rank test, n = 5 except for WT with cecal slurry/
Pseudomonas + /− TUDCA, where n = 10.
www.nature.com/scientificreports/
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bile acid that is produced endogenously in humans at very low levels and has been shown to act as a chemical 
chaperone that decreases ER stress and UPR signaling and protects hepatocytes and pancreatic islets from ER 
stress-induced cytotoxicity14,26. Therefore, we decided to use this and other structurally dissimilar chemical chap-
erones in our in vitro system and demonstrated that this could block Bim induction. We also have demonstrated 
the practicality of blocking ER stress during sepsis using a clinically relevant model using TUDCA, which clearly 
offers a survival advantage in mice. Though these studies are conducted in mice, these findings are translationally 
relevant to humans given the conservation of the mitochondrial apoptotic gene regulation between these two 
species27. We have also provided data using human macrophage cell lines and primary human macrophages as 
well as human target cells showing a similar apoptotic effect. Furthermore, bile acid derivatives such as cheno-
deoxycholic (CDCA) and ursodeoxycholic (UDCA) acid have been used in the past as a cholesterol gallstone 
dissolving agent and in the treatment of chronic cholestatic liver disease28 and the tauryl-derivative of deoxy-
cholicacid (TUDCA) has been shown to be more bioavailable and has been approved for treating cirrhosis and 
gallstones in many countries29. TUDCA is also being used in a phase 2 clinical trial for treating juvenile diabetes 
(NCT02218619), has been shown to improve insulin sensitivity in obese people30 and could be used for treating 
primary biliary cirrhosis or PBC31. Furthermore, a daily dose of 1500 mg for 6 months is well tolerated32 and thus 
appears to have a high therapeutic index. In the context of juvenile diabetes, it has been proposed that TUDCA 
could be administered on an anticipatory basis to individuals at high risk. Similarly, our results suggest that in 
treating sepsis, TUDCA could be offered as a preventative therapeutic agent to vulnerable populations i.e. those 
from the sixth decade of life and above or African-Americans and other non-Caucasian minorities who are con-
sistently at an increased risk of developing sepsis compared to Caucasians.
Materials and Methods
Cell lines and culture conditions. Murine RAW264.7 (Kind gift from Dr. Ashley Mansell, Monash 
University, Melbourne) and MEF cell lines (in-house-derived) were maintained in low glucose DMEM with 10% 
FCS, 2 mM Glutamine, 1% Pen/Strep at 37 °C and 10% CO2. Murine dendritic cell line HAO (Kind gift from 
Prof. Hans Acha-Orbea. University of Lausanne) was maintained in IMDM with 10% FCS, 2 mM Glutamine, 
1% Pen/Strep at 37 °C and 10% CO2. The Jurkat human T-cell line (Kind gift from Lorraine O’Reilly, WEHI, 
Melbourne) was maintained in low glucose DMEM-FMA with 10% FCS, 2 mM Glutamine, 1% Pen/Strep, 250 μ M 
L-asparagine and 50 μ M β -Mercaptoethanol at 37 °C with 5% CO2 MEFs, Murine RAW264.7 macrophages were 
Figure 6. TUDCA treatment does not impair cytokine secretion during polymicrobial sepsis. (A) Mice 
were injected with cecal slurry and serum cytokine levels 6 h post-injection were measured by cytokine bead 
array. (B) Bim protein levels in these mice were analysed by Western blot. Error bars + /− SEM, n = 3; unpaired, 
two-tailed Student’s t - test, *p < 0.005 and #statistically non-significant.
www.nature.com/scientificreports/
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seeded at 1 × 105 cells/mL in complete DMEM 10% FCS, 2 mM Glutamine, 1% Pen/Strep prior to activation 
and incubated overnight at 37 °C 5% CO2. The cells were activated with LPS (100 ng/ml) or with LPS plus deox-
ynivalenol (200 ng/ml) in DMEM, RPMI or FMA (depending on the target cells) for the indicated time points. 
Conditioned supernatant was harvested 24 hour post activation and filter-sterilized using 0.22 μ m filters and 
either used for experiments directly or kept at − 80 °C. THP-1 and U937 cells (human peripheral blood monocyte 
cell lines, originally from Dr. John Silke, WEHI, Melbourne) were maintained in RPMI-1640 containing 10% FCS 
at 37 °C and 5% CO2.
Reagents and antibodies. Anti-Bim 3C5 (Enzo Life Sciences, Lausen, Switzerland), anti-CHOP and 
anti-actin antibodies were described elsewhere9. Anti-BiP antibody was a kind gift from Prof. Mary-Jane 
Gething. Chemical chaperones Genistein (Cat # G6649), Dorsomorphin/compound c (Cat # P5499) and TUDCA 
(Cat # T0682) were purchased from Sigma-Aldrich (Castle Hill NSW, Australia) and used at the indicated 
concentrations.
Cell death assay. For cell death assay, cells were stained with annexin V-FITC or annexin V-AF688 (in house 
reagents) at the indicated time points at appropriate dilutions followed by PI staining (1 μ g/ml, final concentration). 
For measuring apoptosis in tissue sections at the indicated time points, TUNEL staining was carried out as 
described previously33.
Protein/RNA analyses. Protein analysis was carried out by Western blot analysis as described before.9 
RNA analysis was carried out by digital PCR as described before33. The oligos used for digital PCR were 
XBP1-S (F): 5′ -AAGAACACGCTTGGGAATGG-3′ , XBP1-S (R): 5′ -CTGCACCTGCTGCGGAC-3′ ; BIM 
(F): 5′ -CGACAGTCTCAGGAGGAACC-3′, BIM (R): 5′ -CCTTCTCCATACCAGACGGA-3′ ; PUMA (F): 
5′ -GCTGAAGGACTCATGGTGAC-3′ and PUMA (R): 5′ -CAAAGTGAAGGCGCACTG-3′ . XBP splicing anal-
ysis by conventional PCR was performed as previously described34.
Animal experiments. All animal experiments were approved by the La Trobe University Animal Ethics 
Committee (Approval numbers AEC12-66 and AC15-20). Animal experiments were performed in accordance 
with the guidelines of the Bureau of Animal Welfare, Agriculture Victoria (AG 1005, 2002, revised 2007).
Cecal slurry injection and the “two-hit” model. The origin and the genotyping protocol for Bim−/− 
mice are described previously22.
For generating cecal slurry, donor mice were euthanised and cecal contents were suspended in 5% dextrose 
solution to a final concentration of 250 mg/mL and stored at − 80 °C. For experimental induction of sepsis, 8–12 
week old Bim−/− and WT littermate mice of both sexes (C57BL/6) were injected (i.p) with 1 gm/kg cecal slurry. 
For in vivo studies using ER stress inhibitor, mice were injected with TUDCA (500 mg/kg) immediately prior to 
injection with the cecal slurry or 5% dextrose solution.
For survival studies, animals were subjected to ‘two-hit’ model adopted from Muenzer et al.35. In brief, 
C57BL/6 and Bim−/− mice were injected with PBS (sham) or 0.5 gm/kg cecal slurry with or without TUDCA 
(500 mg/kg in 0.15 M NaHCO3, pH 7.4) and 3 days post-injection, mice were intra-nasally infected with 
∼ 1.5 × 107 CFU Pseudomonas aeruginosa ATC27853. Mice were monitored every 3–6 hours for 10 days during 
the experiment and animals were culled if their weight dropped < 20% bodyweight.
Cytokine measurement. Serum cytokine levels were measured using BDTM Cytometric Bead Array (Cat # 
552364, BD Biosciences, San Diego CA 92121, USA) following manufacturer’s instructions.
Statistical analysis. GraphPad Prism was used for statistical analyses. P values were calculated either by 
non-paired two-tailed Student’s t - test or by Log-rank test.
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